1. Genomic Medicine in developing and emerging economies: State-of-the-art and future trends
2. Taking genomics from the bench to the bedside in developing countries
3. Genomics and Public Health: China’s Perspective
4. Leveraging International Collaborations to Advance Genomic Medicine in Colombia
5. Screening for hereditary cancer in Latin America
6. Implementing Genomics in the Care of Neuropsychiatric Patients in Latin America
7. Experience in the development of genomics companies during the last 20 years in Argentina
8. Economic evaluation and cost-effectiveness analysis of genomic medicine interventions in developing and emerging countries
9. Raising genomics awareness among the general public and educating healthcare professionals on Genomic Medicine
10. The Genomic Medicine Alliance: A global effort to facilitate the introduction of genomics into healthcare in developing nations
Originally thought to be available only to the world’s wealthiest nations, genomic medicine has developed into a broad range of clinical methods and technologies whose concrete applications are also revolutionizing health systems in many of the world’s resource-limited nations. Genomic Medicine in Emerging Economies: Genomics for Every Nation provides in-depth analysis and key examples of the implementation of medical genomics in low-income nations across the globe, demonstrating how this advancing medical science has already transformed health systems and led to improved patient care in Indonesian, Chilean, Malaysian, Argentinian, Chinese, Sri Lankan, and Colombian populations among others. In addition to defining tools, diagnostics, and treatment pathways at the population-wide level for medical geneticists, genomic researchers, and public health workers to apply in their own work, this book offers an essential, case-study based approach needed to understand how genomic medicine can be used to improve disease-management in a diverse range of economic and social contexts.
- Examines essential concepts and protocols, and economic, social and legal considerations related to the implementation of genomic medicine in resource-limited nations
- Features concrete success stories of the implementation of medical genomics in Indonesian, Nepalese, Chilean, Malaysian, Tanzanian, Argentinian, Chinese, Sri Lankan and Columbian populations, amongst others
- Provides tools, diagnostics and treatment pathways for medical geneticists, genomic researchers and public health workers to apply in their own work
- Establishes clear precedents on how genomic technologies can be accessed by nations with limited means and financial support for healthcare
Human genetics and genomics researchers and students, practitioners of genomic medicine, healthcare professionals, sociologists, and individuals employed in international development, public health, health economics and regulatory bodies around the world
- No. of pages:
- © Academic Press 2018
- 20th June 2018
- Academic Press
- eBook ISBN:
- Paperback ISBN:
Dr. George Patrinos is an Associate Professor at the University of Patras School of Health Sciences (Department of Pharmacy) in Patras, Greece with Adjunct positions in Rotterdam, the Netherlands and Al-Ain, United Arab Emirates. His research interests span the fields of molecular diagnostics, high-throughput mutation screening, the development of online mutation diagnostic tools, and the implementation of genomics into healthcare, particularly for health systems in developing countries. George Patrinos has published more than 170 scientific papers in peer reviewed journals on topics related to genetics, genomic medicine, pharmacogenomics, molecular diagnostics, and social and economic evaluation for genomic medicine. Dr. Patrinos is also the co-author of Economic Evaluation in Genomic Medicine (2015) and co-Editor of Molecular Diagnostics, Second Edition (2009), both published by Elsevier, and serves as Communicating Editor for the journal Human Mutation. Additionally, he is co-organizer of the international meeting series “Golden Helix Symposia” and “Golden Helix Pharmacogenomics Days”.
Department of Pharmacy, University of Patras School of Health Sciences, Patras, Greece United Arab Emirates University, College of Medicine and Health Sciences, Department of Pathology, Al-Ain, UAE; Erasmus University Medical Center, School of Medicine and Health Sciences, Department of Pathology – Bioinformatics Unit, Rotterdam, the Netherlands.
Dr. Catalina Lopez-Correa is Vice-President and CSO of Genome British Columbia, an organization that leads genomic innovation in British Columbia and facilitates the integration of genomics into society. She has more than 18 years of experience in the field of genomics, particularly in the use of genomic technologies to ensure economic and social impact in resource-limited nations, and the implementation of genomic technologies into health care systems. She has participated in several international initiatives on the implementation of genomics and is scientific advisor to the company BioGenomas which offers genetic testing services in Colombia. Since 2002, Dr. Lopez-Correa has also served as evaluator for large multinational projects funded by the European Commission, the IMI (Innovative Medicines Initiatives) and the NIH and has been recognized by several awards nationally and internationally. As part of her commitment to international development, Dr. Lopez-Correa funded the not-for-profit organization ODNS (Organisation pour le Développement avec des Nouvelles Solidarités) in 2012 and has been involved in several initiatives aimed at demonstrating the impact of genomics in developing countries. Dr. Lopez-Correa has published 9 scientific papers in peer reviewed journals on topics ranging from human genomics to genomic medicine implementation and molecular pathology.
Vice-President and CSO, Genome British Columbia